矩阵刚度通过SCD1依赖的脂质代谢重编程来增强PDAC化学阻力
Xue Zhang1,2, Biwen Zhu1,3, Jiashuai Yan1,3
1Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong University, Nantong 226001, PR China.
Regenerative biomaterials
|July 31, 2025
概括
胰腺管道腺癌 (PDAC) 细胞
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 胰腺管腺癌 (PDAC) 细胞与它们的机械微环境相互作用.
- 瘤进展涉及代谢重编程,影响化学抵抗.
- 将矩阵刚度与PDAC化学抵抗联系在一起的机制尚未完全理解.
研究的目的:
- 为了研究脂质代谢在矩阵刚度介导的PDAC化学抵抗中的作用.
- 为了阐明底层的分子机制.
主要方法:
- RNA测序和非目标代谢学.
- 分析与脂质发生相关的基因表达 (FASN,ACLY,ACC).
- 使用C75 (FASN抑制剂) 和CAY10566 (SCD1抑制剂) 的抑制研究,以及shSCD1.
- 调查Piezo1,Ca2+流入以及PI3K/Akt路径的参与.
主要成果:
- 刚性基质增加了脂质代谢,由升高的脂质生成基因,脂质滴和甘油三酸证明.
- 脂肪酸合成抑制 (C75) 逆转了化学抵抗.
- SCD1表达被上调,对于矩阵刚度介导的化学电阻至关重要.
- 通过Piezo1激活,Ca2+流入以及PI3K/Akt路径调节SCD1的上调.
结论:
- 脂质代谢重编程,特别是通过Piezo1信号的SCD1上调,有助于矩阵刚度介导的PDAC化学抵抗.
- 这项研究为PDAC化学抵抗机制提供了新的见解,并提出了潜在的治疗策略.
相关概念视频
02:34Inhibition of Cdk Activity
6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K